Issue 43 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

37

No.

43

November 18, 2011Nov 18, 2011

Free

DOWNLOAD THE PDF

ACS Creates $1 Billion Nationwide Organization, Taking Fiduciary Control From 12 Divisions

With No Budget in Sight, NCI Takes Careful Steps; Success Rate Last Year Was 14 percent

FDA Revokes Avastin’s Accelerated Approval In Metastatic Breast Cancer Indication

Industry Groups Lobby for Lower Standards for FDA Approval

Recent Issues

Volume 52 | Issue 38 - October 16, 2026

Volume 52 | Issue 37 - October 09, 2026

Volume 52 | Issue 36 - October 02, 2026

Volume 52 | Issue 35 - September 25, 2026

Volume 52 | Issue 34 - September 18, 2026

Volume 52 | Issue 33 - September 11, 2026